Parallax Volatility Advisers
CDMO

Parallax Volatility Advisers’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Parallax Volatility Advisers’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-60
Closed – – 4144
2018
Q3 		$0 Buy
+60
New +$356 ﹤0.01% 3784

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Parallax Volatility Advisers's CDMO Position: Q4 2018 in Review

Parallax Volatility Advisers sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2018, closing a stake of 60 shares.

Parallax Volatility Advisers first reported a position in CDMO in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 101 funds tracked by Wall St. Rank hold CDMO as of Q4 2018.

  • Parallax Volatility Advisers reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 60 Avid Bioservices, Inc. Common Stock shares in Q4 2018.
  • Parallax Volatility Advisers first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Parallax Volatility Advisers's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q3 2018.
  • 101 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2018.

Based on Parallax Volatility Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.